These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 38299151)

  • 21. Structure and Function of Ligand CX3CL1 and its Receptor CX3CR1 in Cancer.
    Lu X
    Curr Med Chem; 2022; 29(41):6228-6246. PubMed ID: 35770395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lupus gut microbiota transplants cause autoimmunity and inflammation.
    Ma Y; Guo R; Sun Y; Li X; He L; Li Z; Silverman GJ; Chen G; Gao F; Yuan J; Wei Q; Li M; Lu L; Niu H
    Clin Immunol; 2021 Dec; 233():108892. PubMed ID: 34813937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of CX3CL1/CX3CR1 Signaling Axis Activity in Osteoporosis.
    Wojdasiewicz P; Turczyn P; Dobies-Krzesniak B; Frasunska J; Tarnacka B
    Mediators Inflamm; 2019; 2019():7570452. PubMed ID: 31780870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut microbiota differently contributes to intestinal immune phenotype and systemic autoimmune progression in female and male lupus-prone mice.
    Johnson BM; Gaudreau MC; Gudi R; Brown R; Gilkeson G; Vasu C
    J Autoimmun; 2020 Mar; 108():102420. PubMed ID: 32019684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CX3CL1 Signaling in the Tumor Microenvironment.
    Conroy MJ; Lysaght J
    Adv Exp Med Biol; 2020; 1231():1-12. PubMed ID: 32060841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alteration in gut microbiota is associated with dysregulation of cytokines and glucocorticoid therapy in systemic lupus erythematosus.
    Guo M; Wang H; Xu S; Zhuang Y; An J; Su C; Xia Y; Chen J; Xu ZZ; Liu Q; Wang J; Dan Z; Chen K; Luan X; Liu Z; Liu K; Zhang F; Xia Y; Liu X
    Gut Microbes; 2020 Nov; 11(6):1758-1773. PubMed ID: 32507008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Possible Role of Dysbiosis of the Gut Microbiome in SLE.
    Kalayci FNC; Ozen S
    Curr Rheumatol Rep; 2023 Dec; 25(12):247-258. PubMed ID: 37737528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of CX3CR1 expression in circulating T cells of systemic lupus erythematosus patients as a reflection of autoimmune status through characterization of cytotoxic capacity.
    Li Q; Yuan Z; Bahabayi A; Zhang Z; Zeng X; Kang R; Xu Q; Guan Z; Wang P; Liu C
    Int Immunopharmacol; 2024 Jan; 126():111231. PubMed ID: 38016349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CX
    Cabana-Puig X; Lu R; Geng S; Michaelis JS; Oakes V; Armstrong C; Testerman JC; Liao X; Alajoleen R; Appiah M; Zhang Y; Reilly CM; Li L; Luo XM
    Inflamm Res; 2023 May; 72(5):1083-1097. PubMed ID: 37060359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of microbiota in the pathogenesis of lupus: Dose it impact lupus nephritis?
    Rahbar Saadat Y; Hejazian M; Bastami M; Hosseinian Khatibi SM; Ardalan M; Zununi Vahed S
    Pharmacol Res; 2019 Jan; 139():191-198. PubMed ID: 30471408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of gut microbiota in different murine models of systemic lupus erythematosus.
    Lu R; Luo XM
    Autoimmunity; 2024 Dec; 57(1):2378876. PubMed ID: 39014962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in systemic lupus erythematosus and microbiota: from bench to bedside.
    Zhan Y; Liu Q; Zhang B; Huang X; Lu Q
    Front Med; 2022 Oct; 16(5):686-700. PubMed ID: 36318354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crosstalk between the CX3CL1/CX3CR1 Axis and Inflammatory Signaling Pathways in Tissue Injury.
    Zhuang Q; Ou J; Zhang S; Ming Y
    Curr Protein Pept Sci; 2019; 20(8):844-854. PubMed ID: 30843484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CX3CL1 promotes MMP-3 production via the CX3CR1, c-Raf, MEK, ERK, and NF-κB signaling pathway in osteoarthritis synovial fibroblasts.
    Hou SM; Hou CH; Liu JF
    Arthritis Res Ther; 2017 Dec; 19(1):282. PubMed ID: 29268768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Distinct Plasma Microbiome But Not Gut Microbiome in Patients With Systemic Lupus Erythematosus Compared to Healthy Individuals.
    James WA; Ogunrinde E; Wan Z; Kamen DL; Oates J; Gilkeson GS; Jiang W
    J Rheumatol; 2022 Jun; 49(6):592-597. PubMed ID: 35169056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical application of protein biomarkers in lupus erythematosus and lupus nephritis.
    Qi S; Chen Q; Xu D; Xie N; Dai Y
    Lupus; 2018 Sep; 27(10):1582-1590. PubMed ID: 29720035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders.
    Pawelec P; Ziemka-Nalecz M; Sypecka J; Zalewska T
    Cells; 2020 Oct; 9(10):. PubMed ID: 33065974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CX3CL1 deficiency ameliorates inflammation, apoptosis and accelerates osteogenic differentiation, mineralization in LPS-treated MC3T3-E1 cells via its receptor CX3CR1.
    Lu Z; Zhang A; Dai Y
    Ann Anat; 2023 Feb; 246():152036. PubMed ID: 36436718
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Guo M; Lu M; Chen K; Xu R; Xia Y; Liu X; Liu Z; Liu Q
    mSphere; 2023 Aug; 8(4):e0007023. PubMed ID: 37366641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemokines and common variable immunodeficiency; possible contribution of the fractalkine system (CX3CL1/CX3CR1) to chronic inflammation.
    Fevang B; Yndestad A; Damås JK; Bjerkeli V; Ueland T; Holm AM; Beiske K; Aukrust P; Frøland SS
    Clin Immunol; 2009 Feb; 130(2):151-61. PubMed ID: 18938112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.